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Polyketide synthases (PKSs) are biosynthetic assembly lines for production of powerful natural products with diverse biological
activities. To understand PKSs’ key steps of acyl-CoA extender unit selection, Bonnett et al. analyze a PikAIV PKSmodel system
using fluorescent-probe assay for steady state kinetic analysis and Fourier transform ion cyclotron resonance-mass spec-
trometry (FTICR-MS) to monitor active site occupancy. Findings from different enzyme variants and model substrates suggest
a mechanism based on acyl-CoA substrate loading followed by differential rates of hydrolysis, which might help fine tune future
pathway engineering efforts.Chemistry &Modulating Sec61
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Cotransins are cyclic heptadepsipeptides that bind the Sec61 trans-
locon and inhibit cotranslational translocation of a subset of secreted
and transmembrane proteins. Now Maifeld et al. show that subtle
structural differences among cotransins can profoundly affect the
extent to which different secretory proteins are inhibited. Secretory
protein profiling revealed tumor necrosis factor alpha (TNFa), a major
drug target for inflammatory diseases, as the most cotransin-sensi-
tive protein discovered to date.Getting Hooks into a Hookworm
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Macrophage migration inhibitory factor (MIF) is a cytokine-like
molecule that is involved in proinflammatory responses and cell
homeostasis. MIF is also expressed by parasitic organisms. Choet al. previously proposed that hookwormMIF (AceMIF) functions to evade the immune response. In this paper, the authors report
the identification of small molecule hookworm MIF inhibitors. A promising inhibitor turned out to be a well-known diuretic,
furosemide. Through structure-activity relationship studies, a nondiuretic furosemide analog was found and cocrystallized
with AceMIF, providing a molecular probe for further investigation of the host-parasite relationship.Genome-Mining Expedition towards Dihydrophenylalanine
PAGE 1102
As microbial genome sequence information is generated at an exponential rate, we continue to observe a growing biosynthetic
potential for the construction of structurally diverse small molecules, some of which may regulate complex symbiotic interactions
or have therapeutic applications. Genome-mining using recently discovered prephenate decarboxylase enzyme sequences has
led Crawford et al. to the discovery of a previously orphaned eight gene cluster in the genomes of the plant pathogen E. amylovora
and the insect pathogen P. luminescens. Genetic and biochemical work presented herein has connected this cluster to the
synthesis of dihydrophenylalanine and onward to a dihydrostilbene derivative.Peptoid Holds a Promise for Huntington’s Disease
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Huntington’s disease (HD) is a neurodegenerative disorder caused by a polyglutamine expan-
sion within Huntingtin (Htt) protein. In the unbiased screen of peptoid library, Chen et al. iden-
tified a HQP09 peptoid that specifically binds to mHtt. The authors demonstrate that HQP09
peptoid inhibited aggregation of mHtt and exerted calcium-stabilizing and neuroprotective
effects in primary striatal neuronal cultures derived from HD mice. They further establish
that intracerebroventricular delivery of HQP09 to an HD mouse model resulted in reduced
accumulation of mHtt brain aggregates and improved motor perfromance. These results
suggest that HQP09 peptoid hold promise for developing treatments for HD and other poly-
glutamine expansion disorders.Switching Single G-protein Subunits
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Trimeric G-proteins are crucial switching platforms for receptor-mediated signal transduction networks. Here, Putyrski et al.
introduce an artificial switch technique based on the use of a chemical dimerizer to independently activate single G-protein
subunits. This permits downstream response patterns such as calcium oscillations to be assigned to the activity of a single
G-protein subunit. This method will largely facilitate the analysis of G-protein-coupled receptor signaling in the future.Biology 18, September 23, 2011 ª2011 Elsevier Ltd All rights reserved v
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CoenzymeQ (Q) is a redox-active lipid essential for respiration in eukaryotic cells. Q biosynthesis requires at least eleven proteins
in S. cerevisiae but the precise function of several of them is not known. Ozeir et al. establish that the predicted monooxygenase
Coq6 is involved in the C5-hydroxylation reaction. The authors demonstrate that synthetic analogs of 4-hydroxybenzoic acid
(4-HB) such as 3,4-dihydroxybenzoic acid and vanillic acid bypass Coq6 deficiency in S. cerevisiae. This work suggests that
hydrophilic analogs of 4-HB may restore Q biosynthesis in patients with some primary Q deficiencies by bypassing the altered
biosynthetic step.vi Chemistry & Biology 18, September 23, 2011 ªSystems View of PDZ-PDZ Interactions
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PDZ domains are best known for mediating protein-protein interactions by
binding the C termini of their target proteins. They have also been reported,
however, to dimerize with other PDZ domains. To further characterize this
alternative binding mode, Chang et al. undertook an unbiased, proteome-wide
investigation of mammalian PDZ-PDZ interactions using protein microarrays,
fluorescence polarization, and coaffinity purification. In total, the authors identi-
fied 37 PDZ-PDZ interactions involving 30% of all PDZ domains tested, indi-
cating that PDZ-PDZ dimerization occurs at a higher frequency than previously
appreciated. This suggests that many PDZ domains evolved to form multiprotein
complexes by simultaneously interacting with more than one ligand.Flexing the Reprogramming Muscle
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Muscle regeneration is profoundly impaired upon aging and in muscular dystrophies. One promising approach is to reprogram
differentiated muscle to their progenitors that can be utilized for cell therapy. Previous attempts failed to unequivocally show that
multinucleated muscle cells can undergo dedifferentiation and contribute to muscle regeneration. Here, Paliwal and Conboy
irreversibly labeled differentiated skeletal muscle cells and reprogrammed them to muscle progenitors for in vivo muscle repair.
This was accomplished using small molecules without gene overexpression, which is safe for therapies. This presents a novel
paradigm of cell fate reversal and creates novel clinical approaches for improved muscle regeneration.
Activators of Cylindrical Proteases as Antimicrobials
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ClpP is a cylindrical protease whose ability to degrade proteins is regulated by ATP-dependent unfoldase chaperones. Leung
et al. used ClpP as a target in a high-throughput screen for compounds which activate the protease and allow it to degrade larger
proteins. The screen resulted in five structurally distinct compounds designated as activators of self-compartmentalizing
proteases 1 to 5 (ACP1 to 5). The ACP1 chemical structure was considered to have drug-like characteristics and was further
optimized to give analogs with bactericidal activity. Hence, the ACPs represent classes of compounds that can activate ClpP
and that can be developed as potential novel antibiotics.No More IgE Clustering on Mast Cells
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Heterobivalent ligands (HBLs) were engineered by Handlogten et al. to inhibit the binding of
allergens to mast cell-bound IgE antibodies, thus inhibiting IgE clustering, which leads to
mast cell degranulation. The HBLs simultaneously bound to the antigen binding site and prox-
imal ‘‘unconventional nucleotide binding site’’ on IgE Fab domain. Simultaneous bivalent
binding provides HBLs with greater than 100-fold enhancement both in avidity for IgEDNP
and in inhibition of allergen binding to IgEDNP compared to the monovalent allergen. Further-
more, in cellular assays HBLs were able to inhibit receptor signaling and thereby inhibit
degranulation of mast cells, while monovalent allergen was not.
Peptide Nucleic Acids Block the CCR5
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CCR5 is a chemokine receptor required for HIV-1 entry into human cells, making it an attractive target for gene therapy. Optimized
triplex-forming peptide nucleic acids (PNAs) were developed by Schleifman et al. to stimulate recombination at the CCR5 locus,
with donor DNAs designed to introduce inactivating stop codons. Site-specific disruption of the CCR5 gene was achieved in
2.46% of human cells in a single treatment, with extremely low off-target effects compared to alternative approaches based
on zinc-finger nucleases. The targeted CCR5 modification induced by the PNAs rendered cells resistant to HIV-1 infection,
providing proof-of-principle for possible therapeutic application.2011 Elsevier Ltd All rights reserved
